Science Explorer Interactive view Map
Company · Seattle · United States

Omeros Corporation (United States)

Research works
68
▲ 39% vs 2013–17
Citations
2.6k
38.5 per fractional work
Top-10% rate
17.7%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: Omeros Corporation (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.95× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 21.85× its world share, 2 worksImmunology and Micro…Neuroscience: 1.09× its world share, 0 worksNeuroscienceHealth Professions: 0.47× its world share, 0 worksHealth ProfessionsMedicine: 3.17× its world share, 6 worksMedicineBusiness, Management and Accounting: 1.15× its world share, 0 worksBusiness, Management…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 21.9×. Every wedge is a field page.

Who are the top researchers at Omeros Corporation (United States)?

Ranked on the composite score, Philip Morrissey lead among researchers whose main affiliation is Omeros Corporation (United States).

  1. 1 Philip Morrissey United States · #424,710 worldwide 72 citations · 18 works
All ranked researchers at Omeros Corporation (United States)

Which keywords describe research at Omeros Corporation (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Innate Immunity, Inflammation, Regulation, Immunity, Cancer Immunotherapy, Complement, Immune and Genetics.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation8▲ 4.8×31 topics
  2. Innate Immunity6▲ 28×6 topics
  3. Regulation4▲ 9.9×4 topics
  4. Cancer4▲ 4.1×13 topics
  5. Immunity4▲ 17×6 topics
  6. Cancer Immunotherapy4▲ 40×3 topics
  7. Genetics4▲ 6.7×3 topics
  8. Machine Learning4▲ 2.4×5 topics
  9. Complement3▲ 235×1 topic
  10. Immune3▲ 235×1 topic
  11. Deep Learning3▲ 2.3×4 topics
  12. Gene Expression3▲ 6.3×5 topics
  13. Glycosylation3▲ 17×2 topics
  14. Image Processing3▲ 12×2 topics
  15. Monoclonal Antibodies2▲ 26×3 topics
  16. Bioimage Analysis2▲ 136×1 topic
  17. High-Content Screening2▲ 136×1 topic
  18. Dendritic Cells2▲ 29×2 topics
  19. Pharmacology2▲ 10×3 topics
  20. Reactive Oxygen Species2▲ 6.7×7 topics
  21. Therapeutic Antibodies2▲ 27×2 topics
  22. Therapeutic Targets2▲ 15×4 topics
  23. Antibody Engineering2▲ 32×1 topic
  24. Fc Receptors2▲ 32×1 topic
  25. Antigen Presentation2▲ 30×2 topics
  26. Immune Regulation2▲ 23×3 topics
  27. Stress2▲ 7.3×3 topics
  28. Toll-like Receptors2▲ 17×3 topics
  29. Tumor Antigen2▲ 37×1 topic
  30. Vaccine Adjuvants2▲ 37×1 topic
  31. Macrophages2▲ 17×2 topics
  32. CD472▲ 168×1 topic
  33. apoptotic cells2▲ 168×1 topic
  34. NK Cell Recognition2▲ 24×1 topic
  35. Natural Killer Cells2▲ 24×1 topic
  36. Pattern Recognition Receptors2▲ 16×2 topics
  37. Tumor Targeting2▲ 18×3 topics
  38. Autoimmunity2▲ 11×4 topics
  39. Glaucoma2▲ 14×2 topics
  40. Thrombosis2▲ 10×4 topics

Which research topics does Omeros Corporation (United States) publish most on?

By volume in 2022–2025: Complement system in diseases, Monoclonal and Polyclonal Antibodies Research, Renal Diseases and Glomerulopathies and Systemic Lupus Erythematosus Research.

  1. 1 Complement system in diseases Immunology 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Renal Diseases and Glomerulopathies Nephrology 1 works
  4. 4 Systemic Lupus Erythematosus Research Rheumatology 0 works
  5. 5 Renal Transplantation Outcomes and Treatments Transplantation 0 works
  6. 6 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works
  7. 7 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  8. 8 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
  9. 9 Blood groups and transfusion Hematology 0 works
  10. 10 Management and Organizational Studies Organizational Behavior and Human Resource Management 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.4%not open57.6%

World: 28% of research is openly available.

with international co-authors30.7%domestic only69.3%

World: 19% is written across borders.

How has Omeros Corporation (United States)'s research output changed?

Output in 2018–2022 was 39% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seattle

All research institutions in Seattle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.